Holen Sie sich die Stockscreener-App
31.11
2.20%
0.67
Schlusskurs vom Vortag:
$30.44
Offen:
$31.88
24-Stunden-Volumen:
13,827
Relative Volume:
0.28
Marktkapitalisierung:
$291.73M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.98%
1M Leistung:
+19.70%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$30.24
$31.88
1-Wochen-Bereich:
$28.20
$31.88
52-Wochen-Spanne:
$15.80
$34.31
Tvardi Therapeutics Inc Stock (TVRD) Company Profile
Firmenname
Tvardi Therapeutics Inc
Sektor
Branche
Telefon
(713) 489-8654
Adresse
3 SUGAR CREEK CTR. BLVD., SUGAR LAND
Vergleichen Sie TVRD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TVRD
Tvardi Therapeutics Inc
|
31.11 | 285.45M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Tvardi Therapeutics Inc Stock (TVRD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-14 | Eingeleitet | Raymond James | Outperform |
| 2025-07-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-21 | Eingeleitet | Oppenheimer | Outperform |
| 2025-05-15 | Eingeleitet | BTIG Research | Buy |
| 2024-06-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-06-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-06-13 | Herabstufung | Needham | Buy → Hold |
| 2024-06-13 | Herabstufung | Stifel | Buy → Hold |
| 2023-03-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-11-01 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-08-03 | Eingeleitet | JP Morgan | Neutral |
| 2020-04-21 | Bestätigt | H.C. Wainwright | Buy |
| 2019-08-12 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-29 | Bestätigt | Laidlaw | Buy |
| 2019-02-06 | Fortgesetzt | Jefferies | Buy |
| 2019-01-15 | Eingeleitet | BofA/Merrill | Neutral |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Eingeleitet | Jefferies | Buy |
| 2018-08-08 | Bestätigt | Stifel | Buy |
| 2018-06-28 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-12 | Fortgesetzt | H.C. Wainwright | Buy |
| 2018-02-12 | Hochstufung | Janney | Neutral → Buy |
| 2018-01-19 | Eingeleitet | Seaport Global Securities | Buy |
Alle ansehen
Tvardi Therapeutics Inc Aktie (TVRD) Neueste Nachrichten
Can trapped investors hope for a rebound in Tvardi Therapeutics Inc.July 2025 Retail & Free High Return Stock Watch Alerts - Newser
Identifying reversal signals in Tvardi Therapeutics Inc.Weekly Risk Summary & Weekly Momentum Picks - Newser
How to manage a losing position in Tvardi Therapeutics Inc.Trade Exit Report & Safe Entry Zone Identification - Newser
Does Tvardi Therapeutics Inc. qualify in momentum factor screeningGap Up & Expert Curated Trade Setups - Newser
Is now a turning point for Tvardi Therapeutics Inc.July 2025 Weekly Recap & Weekly Momentum Picks - Newser
Tvardi Therapeutics Inc. stock chart pattern explainedJuly 2025 Volume & AI Optimized Trade Strategies - Newser
How to read the order book for Tvardi Therapeutics Inc.Exit Point & Stepwise Trade Signal Guides - Newser
Can Tvardi Therapeutics Inc. deliver consistent EPS growth2025 Big Picture & Real-Time Buy Signal Alerts - خودرو بانک
Why is Tvardi Therapeutics Inc. stock going upMarket Performance Summary & Free Verified High Yield Trade Plans - خودرو بانک
What momentum shifts mean for Tvardi Therapeutics Inc.July 2025 Setups & AI Powered Market Entry Ideas - Newser
How institutional ownership impacts Tvardi Therapeutics Inc. stockExit Point & Expert Approved Momentum Ideas - Newser
Short interest data insights for Tvardi Therapeutics Inc.Quarterly Growth Report & Accurate Intraday Trading Signals - Newser
Is it too late to sell Tvardi Therapeutics Inc.Earnings Miss & Short-Term High Return Strategies - Newser
Tvardi Posts Q2 Net Income Turnaround - AOL.com
How sentiment analysis helps forecast Tvardi Therapeutics Inc.Market Activity Summary & Technical Entry and Exit Alerts - Newser
What are Tvardi Therapeutics Inc.’s technical support levelsEarnings Growth Summary & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Real time social sentiment graph for Tvardi Therapeutics Inc.GDP Growth & Safe Capital Growth Tips - Newser
Can Tvardi Therapeutics Inc. outperform in the next rally2025 Performance Recap & Community Trade Idea Sharing Platform - خودرو بانک
What machine learning models say about Tvardi Therapeutics Inc.Quarterly Growth Report & Expert Approved Momentum Ideas - Newser
Ranking Tvardi Therapeutics Inc. among high performing stocks via toolsQuarterly Trade Report & Community Verified Swing Trade Signals - Newser
Using data filters to optimize entry into Tvardi Therapeutics Inc.July 2025 Retail & Daily Chart Pattern Signals - Newser
When is the best time to exit Tvardi Therapeutics Inc.Dip Buying & Free Weekly Watchlist of Top Performers - Newser
How to use Fibonacci retracement on Tvardi Therapeutics Inc.July 2025 Fed Impact & Technical Buy Zone Confirmations - Newser
Visual trend scoring systems applied to Tvardi Therapeutics Inc.Quarterly Profit Review & Daily Oversold Bounce Ideas - Newser
Building trade automation scripts for Tvardi Therapeutics Inc.Bull Run & Risk Controlled Stock Pick Alerts - Newser
What’s Tvardi Therapeutics Inc.’s historical returnShare Buyback & Consistent Return Investment Signals - خودرو بانک
Will breakout in Tvardi Therapeutics Inc. lead to full recoveryJuly 2025 Big Picture & High Return Stock Watch Alerts - Newser
Is Tvardi Therapeutics Inc. stock poised for growthMarket Performance Summary & Weekly High Potential Alerts - Newser
Is Tvardi Therapeutics Inc. reversing from oversold territoryTrade Volume Report & Reliable Intraday Trade Alerts - Newser
What’s the RSI of Tvardi Therapeutics Inc. stockQuarterly Earnings Summary & Consistent Profit Trading Strategies - خودرو بانک
What recovery options are there for Tvardi Therapeutics Inc.July 2025 PreEarnings & AI Enhanced Trading Alerts - Newser
What are the analyst revisions for Tvardi Therapeutics Inc.Is QNST stock a good investment in YEAR2025 Dividend Review & AI Based Trade Execution Alerts - خودرو بانک
Tvardi Therapeutics Inc. Included in Top Momentum Scan getLinesFromResByArray error: size == 0 - thegnnews.com
Why Tvardi Therapeutics Inc. is moving todayJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - Newser
Applying Elliott Wave Theory to Tvardi Therapeutics Inc.Inflation Watch & Free Expert Verified Stock Movement Alerts - Newser
Finanzdaten der Tvardi Therapeutics Inc-Aktie (TVRD)
Es liegen keine Finanzdaten für Tvardi Therapeutics Inc (TVRD) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Tvardi Therapeutics Inc-Aktie (TVRD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. |
Feb 28 '25 |
Sale |
4.76 |
163 |
776 |
7,190 |
| Posner Christopher | PRESIDENT AND CEO |
Feb 04 '25 |
Sale |
4.72 |
372 |
1,756 |
13,692 |
| Posner Christopher | PRESIDENT AND CEO |
Nov 04 '24 |
Sale |
0.29 |
3,668 |
1,064 |
168,768 |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):